Abstract
This study compared the performance of an itemized symptom self-report (Inventory of Depressive Symptomatology - Self-Report; IDS-SR), patient global ratings, and clinician global ratings with an itemized clinician-rated symptom severity measure (Inventory of Depressive Symptomatology - Clinician-Rated; IDS-C) in detecting treatment effects in patients with major depressive disorder (MDD). A total of 28 inpatients (30.8% psychotic) and 34 outpatients (17.9% psychotic) with MDD began treatment that followed the Texas medication algorithm. The clinicians completed the IDS-C and a Physician Global Rating Scale (PhGRS) at each assessment visit, while the patients completed the IDS-SR and a Patient Global Rating Scale (PtGRS). Change scores from the baseline to subsequent weeks were computed for all subjects, utilizing all four measures. The IDS-SR was a significant independent predictor of the response to treatment as compared to the two global ratings. The IDS-SR was as sensitive to change as the IDS-C. While the clinician-rated itemized symptom severity rating scale remains the standard to assess the symptomatic outcome of the treatment of MDD, a self-report of identical symptomatology may be a reasonable alternative for many patients. (C) Published by Elsevier Science Ireland Ltd.
Original language | English (US) |
---|---|
Pages (from-to) | 269-279 |
Number of pages | 11 |
Journal | Psychiatry research |
Volume | 96 |
Issue number | 3 |
DOIs |
|
State | Published - Nov 20 2000 |
Keywords
- Global measures
- Major depressive disorder
- Self-reports
- Symptom severity
ASJC Scopus subject areas
- Psychiatry and Mental health
- Biological Psychiatry